Kesler Norman & Wride’s Eli Lilly LLY Stock Holding History

Kesler Norman & Wride’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.17M	Buy	5,979 +834	+16%	+$852K	1.14%	27
2026 Q1	$4.73M	Sell	5,145 -24	-0.5%	-$24.3K	0.81%	43
2025 Q4	$5.55M	Buy	5,169 +395	+8%	+$378K	0.95%	38
2025 Q3	$3.69M	Sell	4,774 -738	-13%	-$549K	0.72%	48
2025 Q2	$4.3M	Buy	5,512 +255	+5%	+$198K	0.76%	47
2025 Q1	$4.34M	Buy	5,257 +483	+10%	+$402K	0.83%	43
2024 Q4	$3.69M	Buy	4,774 +760	+19%	+$629K	0.8%	43
2024 Q3	$3.56M	Buy	4,014 +372	+10%	+$334K	0.7%	48
2024 Q2	$3.3M	Buy	3,642 +657	+22%	+$526K	0.7%	49
2024 Q1	$2.32M	Buy	2,985 +2,263	+313%	+$1.61M	0.49%	67
2023 Q4	$421K	Buy	+722	New	+$421K	0.1%	132

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Kesler Norman & Wride's LLY Position: Q2 2026 in Review

Kesler Norman & Wride increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $852K and bringing the position to 5,979 shares worth $7.17M. The position accounts for 1.14% of the portfolio, ranked #27.

Kesler Norman & Wride first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Kesler Norman & Wride held 5,979 shares of Eli Lilly worth $7.17M as of Q2 2026.
Kesler Norman & Wride bought 834 Eli Lilly shares in Q2 2026, an estimated $852K.
Eli Lilly made up 1.14% of Kesler Norman & Wride's portfolio in Q2 2026, its #27 holding.
Kesler Norman & Wride first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kesler Norman & Wride's 13F filing for Q2 2026, filed 23 Jul 2026.